The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.

Pepe, Jessica; Petrucci, Maria Teresa; Mascia, Maria Lucia; Piemonte, Sara; Fassino, Valeria; Romagnoli, Elisabetta; Minisola, Salvatore

Pepe, Jessica; Petrucci, Maria Teresa; Mascia, Maria Lucia; Piemonte, Sara; Fassino, Valeria; Romagnoli, Elisabetta; Minisola, Salvatore.

Affiliation

Pepe J; Department of Clinical Sciences, University "La Sapienza", Viale del Policlinico 155, 00161 Rome, Italy.

Calcif Tissue Int ; 82(6): 418-26, 2008 Jun.

Article in En | MEDLINE | ID: mdl-18528609

Subject(s)

Alendronate/therapeutic use; Bone Density Conservation Agents/therapeutic use; Monoclonal Gammopathy of Undetermined Significance/drug therapy; Osteoporosis, Postmenopausal/drug therapy; Alkaline Phosphatase/blood; Biomarkers/blood; Bone Density; Calcium, Dietary/administration & dosage; Cholecalciferol/administration & dosage; Collagen Type I/blood; Drug Therapy, Combination; Female; Femur/diagnostic imaging; Femur/metabolism; Humans; Lumbar Vertebrae/diagnostic imaging; Lumbar Vertebrae/metabolism; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance/complications; Monoclonal Gammopathy of Undetermined Significance/metabolism; Osteocalcin/blood; Osteopontin/blood; Osteoporosis, Postmenopausal/complications; Osteoporosis, Postmenopausal/metabolism; Peptides/blood; Radiography; Spinal Fractures/etiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Monoclonal Gammopathy of Undetermined Significance / Osteoporosis, Postmenopausal / Alendronate / Bone Density Conservation Agents Type of study: Diagnostic_studies / Etiology_studies Language: En Journal: Calcif Tissue Int Year: 2008 Type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google